Breaking News Instant updates and real-time market news.

FITB

Fifth Third

$26.76

-0.08 (-0.30%)

12:15
10/15/18
10/15
12:15
10/15/18
12:15

Fifth Third put volume heavy and directionally bearish

Bearish flow noted in Fifth Third with 2,008 puts trading, or 3x expected. Most active are Nov-18 22 puts and Nov-18 24 puts, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 6.39, while ATM IV is up nearly 2 points on the day. Earnings are expected on October 23rd.

  • 23

    Oct

  • 24

    Oct

FITB Fifth Third
$26.76

-0.08 (-0.30%)

09/20/18
WEDB
09/20/18
NO CHANGE
WEDB
Outperform
Fifth Third added to Best Ideas List at Wedbush
Wedbush analyst Jesse Bigelow added Fifth Third Bancorp to the firm's Best Ideas List, telling investors in a research note that the company has several earnings levers that other banks don't have to overcome macro tailwinds that are slowing, including the "elusive" rebound in loan growth and less margin benefit from rate hikes as deposit costs are accelerating.
09/14/18
SPHN
09/14/18
NO CHANGE
SPHN
Subprime lenders weakness may be opportunity, says Stephens
Stephens analyst Vincent Caintic attributes weakness in shares of subprime consumer lenders to news that U.S. Bancorp (USB) is re-entering the small dollar, high yield lending business after Fifth Third (FITB) re-entered two months ago. However, he views the OCC's push for banks to offer small dollar loans as a positive for online lenders and notes that the recent bank announcements are for loans yielding 40%-70%, which competes against products from Regional Management (RM) and World Acceptance (WRLD) but should not impact online lenders. Subprime online lenders include Enova (ENVA) and Elevate Credit (ELVT). Other publicly traded companies in the FinTech space include LendingClub (LC) and On Deck Capital (ONDK).
09/04/18
09/04/18
UPGRADE
Target $34

Outperform
Fifth Third upgraded to Outperform on valuation at Wedbush
As previously reported, Wedbush analyst Peter Winter upgraded Fifth Third (FITB) to Outperform from Neutral following meetings with management. The analyst notes that the stock has been under pressure following the announcement to acquire MB Financial (MBFI) on May 21. However, he believes the news is more than reflected in the valuation. Furthermore, Winter thinks the company can execute on its planned merger with MB Financial, realize the Project North Star targets and new $100M in expense savings, and show improvement toward reaching its FY 2020 goals of ROA, ROTCE and an efficiency in the low 50's. The analyst also raised his price target on Fifth Third's stock to $34 from $31.
09/04/18
WEDB
09/04/18
UPGRADE
WEDB
Outperform
Fifth Third upgraded to Outperform from Neutral at Wedbush

TODAY'S FREE FLY STORIES

CNI

Canadian National

$86.78

0.38 (0.44%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Upgrade
Canadian National rating change  »

Canadian National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 21

    Nov

  • 22

    Nov

INOV

Inovalon

$15.04

0.2 (1.35%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Initiation
Inovalon initiated  »

Citi starts Inovalon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$67.83

1.185 (1.78%)

06:17
10/16/19
10/16
06:17
10/16/19
06:17
Initiation
Wabtec initiated  »

Wabtec initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 13

    Nov

ADBE

Adobe

$279.40

1.61 (0.58%)

06:15
10/16/19
10/16
06:15
10/16/19
06:15
Downgrade
Adobe rating change  »

Citi downgrades Adobe to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 29

    Oct

  • 04

    Nov

PLMR

Palomar

$40.61

-0.26 (-0.64%)

06:13
10/16/19
10/16
06:13
10/16/19
06:13
Initiation
Palomar initiated  »

Palomar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$20.65

2.42 (13.27%)

06:12
10/16/19
10/16
06:12
10/16/19
06:12
Initiation
Axsome Therapeutics initiated  »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNBR

Sleep Number

$46.69

0.48 (1.04%)

06:11
10/16/19
10/16
06:11
10/16/19
06:11
Recommendations
Sleep Number analyst commentary  »

Sleep Number price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNI

Canadian National

$86.78

0.38 (0.44%)

06:11
10/16/19
10/16
06:11
10/16/19
06:11
Upgrade
Canadian National rating change  »

Canadian National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 21

    Nov

  • 22

    Nov

PLMR

Palomar

$40.61

-0.26 (-0.64%)

06:10
10/16/19
10/16
06:10
10/16/19
06:10
Initiation
Palomar initiated  »

Palomar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$218.42

3.27 (1.52%)

06:08
10/16/19
10/16
06:08
10/16/19
06:08
Downgrade
Canadian Pacific rating change  »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

MCK

McKesson

$138.17

4.01 (2.99%)

, ABC

AmerisourceBergen

$83.18

1.6 (1.96%)

06:08
10/16/19
10/16
06:08
10/16/19
06:08
Recommendations
McKesson, AmerisourceBergen, Cardinal Health analyst commentary  »

Barclays ups McKesson…

MCK

McKesson

$138.17

4.01 (2.99%)

ABC

AmerisourceBergen

$83.18

1.6 (1.96%)

CAH

Cardinal Health

$47.93

1.16 (2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

I

Intelsat

$26.09

1.09 (4.36%)

06:05
10/16/19
10/16
06:05
10/16/19
06:05
Hot Stocks
Intelsat and Marlink extend partnership for maritime broadband services »

Intelsat and Marlink have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.00

0.145 (5.09%)

06:03
10/16/19
10/16
06:03
10/16/19
06:03
Recommendations
Foamix analyst commentary  »

Barclays likes Foamix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

TWTR

Twitter

$40.26

0.5 (1.26%)

06:03
10/16/19
10/16
06:03
10/16/19
06:03
Hot Stocks
Twitter clarifies when it will enforce rules against world leaders »

Twitter said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

MOH

Molina Healthcare

$117.37

4.885 (4.34%)

06:02
10/16/19
10/16
06:02
10/16/19
06:02
Hot Stocks
Molina Healthcare to acquire certain assets of YourCare Health Plan for $40M »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

FBM

Foundation Building Materials

$17.55

0.11 (0.63%)

06:01
10/16/19
10/16
06:01
10/16/19
06:01
Upgrade
Foundation Building Materials rating change  »

Foundation Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBSH

Commerce Bancshares

$60.24

0.87 (1.47%)

06:00
10/16/19
10/16
06:00
10/16/19
06:00
Earnings
Commerce Bancshares reports Q3 EPS 98c, consensus 92c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$0.18

-0.0264 (-12.57%)

05:59
10/16/19
10/16
05:59
10/16/19
05:59
Hot Stocks
Applied DNA Sciences enters partnership with Molecular Isotope Technologies »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

GOOG

Alphabet

$1,243.53

25.3 (2.08%)

, GOOGL

Alphabet Class A

$1,242.51

24.9 (2.05%)

05:59
10/16/19
10/16
05:59
10/16/19
05:59
Periodicals
Google staff fighting over decision to ban protest video game app, Vox reports »

Google employees are…

GOOG

Alphabet

$1,243.53

25.3 (2.08%)

GOOGL

Alphabet Class A

$1,242.51

24.9 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

JNJ

Johnson & Johnson

$132.84

2.17 (1.66%)

05:59
10/16/19
10/16
05:59
10/16/19
05:59
Upgrade
Johnson & Johnson rating change  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLND

Millendo Therapeutics

$7.12

0.04 (0.56%)

05:55
10/16/19
10/16
05:55
10/16/19
05:55
Conference/Events
Millendo Therapeutics management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

UCBJF

UCB

$0.00

(0.00%)

05:52
10/16/19
10/16
05:52
10/16/19
05:52
Upgrade
UCB rating change  »

UCB upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFNNY

Infineon

$0.00

(0.00%)

05:51
10/16/19
10/16
05:51
10/16/19
05:51
Downgrade
Infineon rating change  »

Infineon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$71.25

0.97 (1.38%)

, TATYY

Tate & Lyle

$0.00

(0.00%)

05:49
10/16/19
10/16
05:49
10/16/19
05:49
Hot Stocks
Citi appointed as successor depositary bank for Tate & Lyle ADR programme »

Citi (C), acting through…

C

Citi

$71.25

0.97 (1.38%)

TATYY

Tate & Lyle

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

  • 14

    Jan

CBT

Cabot

$43.89

0.17 (0.39%)

05:48
10/16/19
10/16
05:48
10/16/19
05:48
Downgrade
Cabot rating change  »

Cabot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.